European Archives - Page 523 of 1108 - European Medical Journal

Socio-demographic Determinants of Attendance in Diabetes Education Centres: A Survey of Patients’ Views

People with long-term conditions such as diabetes are at greater risk of comorbidity, and anecdotal evidence suggests that it can increase the burden of ongoing COVID-19 pandemic infection.1-3

Amivantamab Successfully Prolongs Survival in Rare Lung Cancer Mutation

Amivantamab has the potential to address the high unmet need in the treatment of people with EGFR exon 20 insertion mutations in non-small cell lung cancer

The Association Between Hypermobility Ehlers–Danlos Syndrome and Other Rheumatologic Diseases

In this feature paper, the authors discuss the prevalence and pathophysiology of rheumatologic conditions, specifically ankylosing spondylitis and rheumatoid arthritis, in patients with hEDS.

Pollutants in Food Causing Heightened Allergic Responses

Recent reports have also found dangerously high levels of toxic heavy metals, including cadmium, in several brands of baby food…

Allergic Reactions to mRNA-Based COVID-19 Vaccines Rare and Clinically Manageable

The research further suggests that the minimal allergic reactions could be avoided by manufacturers through the reformulation of vaccines…

Medicine in the Military

Professor Kenneth Stahl looks at the similarities between doctors and pilots, explore working in trauma management within the Kurdish army.

The hard sell of cell and gene therapies

While the potential of cell and gene therapies (CGTs) is huge, the high cost raises concerns from payers. We explore how the industry can drive the adoption of CGTs to ensure that they reach patients around the world, rather than just those in private markets

Seeking solutions to low income low access

During the pandemic, low-to-middle-income countries (LMICs) have often been reliant on vaccine handouts from global initiatives and affluent nations. What are the emerging solutions that could improve access to vaccines in LMICs and self-sufficiency?

What is possible with preventative technology?

Tech giants have seized a huge share of the health and preventive technology market, but how could partnerships between the pharmaceutical and tech industries benefit patients and healthcare systems?

Interview: Neel Basudev

To be honest, my initial foray into the field of diabetes was by chance, as I took on the management of diabetes at the practice when I joined as a salaried general practitioner.